Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors.

Uslu, Yasemin; Kocatepe, Vildan; Sezgin, Derya Subasi; Uras, Cihan

Uslu, Yasemin; Kocatepe, Vildan; Sezgin, Derya Subasi; Uras, Cihan.

Affiliation

Uslu Y; Istanbul University Nursing Faculty, Suleymaniye, Fatih, Istanbul, Turkey. yaseminuslu86@gmail.com.
Kocatepe V; Izmir Demokrasi University, Health Science Faculty, Izmir, Turkey.
Sezgin DS; Acibadem Mehmet Ali Aydinlar University, Senology Institute, Istanbul, Turkey.
Uras C; Acibadem Mehmet Ali Aydinlar University, Senology Institute, Istanbul, Turkey.

Support Care Cancer ; 31(5): 285, 2023 Apr 20.

Article in En | MEDLINE | ID: mdl-37079089

Subject(s)

Breast Neoplasms; Cancer Survivors; Female; Humans; Adult; Middle Aged; Tamoxifen/therapeutic use; Breast Neoplasms/drug therapy; Antineoplastic Agents, Hormonal/adverse effects; Prospective Studies; Chemotherapy, Adjuvant; Medication Adherence; Adjuvants, Immunologic/therapeutic use; Adjuvants, Pharmaceutic/therapeutic use; Aromatase Inhibitors/therapeutic use

Key words

Adjuvant endocrine therapy; Adjuvant tamoxifen; Breast cancer survivors; Hormonal therapy; Medication adherence

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Cancer Survivors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Language: En Journal: Support Care Cancer Journal subject: NEOPLASIAS / SERVICOS DE SAUDE Year: 2023 Type: Article Affiliation country: Turkey

Fulltext

XML

PubMed Links

Search on Google